Annovis Bio, Inc. (ANVS)
Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs which aim to treat neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Its product pipeline also includes ANVS405 and ANVS301, which focus on the treatment of traumatic brain injury, stroke, and advanced AD. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Malvern, PA.
Address
101 LINDENWOOD DRIVE, SUITE 225
MALVERN, PA 19355
Founded
2008
Number of Employees
6
Website
http://www.annovisbio.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)